Evidence map›Paper›PMID 19395675›Full record

ArticleBlood2009

PAF-acetylhydrolase expressed during megakaryocyte differentiation inactivates PAF-like lipids.

Jason M Foulks, Gopal K Marathe, Noemi Michetti, Diana M Stafforini, Guy A Zimmerman, Thomas M McIntyre, Andrew S Weyrich

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Regulation of the genetic code in megakaryocytes and platelets.Journal of thrombosis and haemostasis : JTH · 2015
    Review
  9. Proteasome function is required for platelet production.The Journal of clinical investigation · 2014
    Article
  10. Article
  11. Article
  12. Lipid peroxidation products as potential bioindicators of Lyme arthritis.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2011
    Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Jason M FoulksDepartment of Experimental Pathology, University of Utah, Salt Lake City, UT 84112, USA.
Gopal K Marathe
Noemi Michetti
Diana M Stafforini
Guy A Zimmerman
Thomas M McIntyre
Andrew S Weyrich
University of Utah · USCleveland Clinic Lerner College of Medicine · USHuntsman Cancer Institute · US

Funding

ROLE OF MICROPARTICLES IN THE ANTI-PHOSPHOLIPID SYNDROMEP50HL081011 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI MCINTYRE, THOMAS · 2006 to 2010
$12.9M
TRANSLATIONAL EVENTS IN PLATELETSR01HL066277 · NHLBI · UNIVERSITY OF UTAH · PI WEYRICH, ANDREW S · 2001 to 2012
$3.8M
Molecular Interactions of Myeloid Cells with EndotheliumR37HL044525 · NHLBI · UNIVERSITY OF UTAH · PI ZIMMERMAN, GUY A. · 2004 to 2013
$3.5M
BIOLOGICAL ACTIVITYP OF OXIDIZED PHOSPHOLIPIDSR01HL044513 · NHLBI · UNIVERSITY OF UTAH · PI MCINTYRE, THOMAS M · 1990 to 2008
$3.0M
METABOLISM OF PLATELET-ACTIVATING FACTORR01HL035828 · NHLBI · UNIVERSITY OF UTAH · PI STAFFORINI, DIANA M · 1986 to 2008
$1.9M
MOLECULAR INTERACTIONS OF MYELOID CELLS WITH ENDOTHELIUMR01HL044525 · NHLBI · UNIVERSITY OF UTAH · PI ZIMMERMAN, GUY A. · 1990 to 2003
$1.2M
NHLBI NIH HHS HL 081011NHLBI NIH HHS HL 35828NHLBI NIH HHS HL-44513NHLBI NIH HHS HL-44525NHLBI NIH HHS HL-66277NHLBI NIH HHS P50 HL081011NHLBI NIH HHS R01 HL035828NHLBI NIH HHS R01 HL044513NHLBI NIH HHS R01 HL044525NHLBI NIH HHS R01 HL066277NHLBI NIH HHS R37 HL044525
6 · The paper itself

Abstract

Platelet activating factor (PAF) and PAF-like lipids induce inflammatory responses in target cells. These lipid mediators are inactivated by PAF-acetylhydrolase (PAF-AH). The PAF signaling system affects the growth of hematopoietic CD34(+) cells, but roles for PAF-AH in this process are unknown. Here, we investigated PAF-AH function during megakaryopoiesis and found that human CD34(+) cells accumulate this enzymatic activity as they differentiate toward megakaryocytes, consistent with the expression of mRNA and protein for the plasma PAF-AH isoform. Inhibition of endogenous PAF-AH activity in differentiated megakaryocytes increased formation of lipid mediators that signaled the PAF receptor (PAFR) in fully differentiated human cells such as neutrophils, as well as megakaryocytes themselves. PAF-AH also controlled megakaryocyte alpha(IIb)beta(3)-dependent adhesion, cell spreading, and mobility that relied on signaling through the PAFR. Together these data suggest that megakaryocytes generate PAF-AH to modulate the accumulation of intracellular phospholipid mediators that may detrimentally affect megakaryocyte development and function.

Indexed as

1-Alkyl-2-acetylglycerophosphocholine EsteraseCalcium SignalingCell AdhesionCells, CulturedEnzyme InductionFetal BloodHematopoietic Stem CellsHumansInterleukin-3MegakaryocytesPhospholipidsPlatelet Glycoprotein GPIIb-IIIa ComplexPlatelet Membrane GlycoproteinsReceptors, G-Protein-CoupledRNA, MessengerStem Cell Factor1-Alkyl-2-acetylglycerophosphocholine EsteraseIL3 protein, humanInterleukin-3Phospholipidsplatelet activating factor receptorPlatelet Glycoprotein GPIIb-IIIa ComplexPlatelet Membrane GlycoproteinsReceptors, G-Protein-CoupledRNA, MessengerStem Cell FactorThrombopoietin

Identifiers

PMID19395675
PMCPMC2710923
OpenAlexW2057108267

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.